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Between April 1993 and May 1995, 17 adult ortho-
topic liver transplant recipients were found to have 
early hepatic artery thrombosis (HAT) after a median 
of 7 postoperative days (mean, 11). The HAT was diag-
nosed in all cases by duplex ultrasound. Thrombec-
tomy was performed with urgent revascularization 
(UR), using an interposition arterial graft procured 
from the cadaveric liver donor, and arterial patency 
was verified with intraoperative angiography. In 
seven cases, intra-arterial urokinase was adminis-
tered after the thrombectomy. Fifteen (88%) of the liv-
ers remained arterialized throughout the follow-up 
period (median, 15 months); the remaining two pa-
tients developed recurrent HAT after 6 and 8 months. 
Although there was a high rate of subsequent compli-
cations, 11 (65%) of the patients are alive without re-
transplantation, with a mean follow-up of 17 months. 
Despite having a patent hepatic artery, the remaining 
six patients (35%) died from infectious complications 
that usually were present before the VR. Thus, DR 
effectively restored arterial inflow in 88% of the pa-
tients with early HAT. The ultimate outcome was de-
termined mainly by the presence of intra-abdominal 
complications at the time of VR. In conclusion, UR, 
rather than retransplantation, should be considered 
the prime treatment option for patients who develop 
early posttransplant HAT. 
Hepatic artery thrombosis (HAT*) remains one of the most 
dreaded complications after orthotopic liver transplantation 
(OLT). Earlier series reported that HAT occurred in about 
10% of recipients (1-6), with even higher rates reported for 
children (1, 2, 7-12). In early days, up to 50% of these pa-
tients died without retransplantation; significantly more 
died when HAT developed in the early posttransplant period 
(2,13). Those who did survive with HAT suffered significant 
morbidity, primarily related to septic hepatic gangrene of the 
liver and complications of the biliary tree (1, 2, 13-20). Al-
though retransplantation has been credited with reducing 
the mortality of HAT (2, 13, 21), the inadequate supply of 
donor organs has limited this option. 
While the feasibility has been reported of using urgent 
revascularization (UR) to avoid the need for retransplanta-
tion (22-24), this alternative strategy depends on early diag-
nosis. Innovations in duplex ultrasound (DUS) technology 
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have provided an accurate noninvasive method for detection 
of HAT before irreversible ischemic damage of the allograft 
occurs (25). Here, we report our results with UR in 17 adult 
OLT recipients with early HAT. 
PATIENTS AND METHODS 
Between April 1993 and May 1995, 492 liver transplantations 
were performed in adult recipients at the University of Pittsburgh. 
Seventeen of these patients underwent UR for HAT within 30 days 
of OLT. Follow-up information was available in all cases. Patient 
selection, organ procurement, the recipient operation, intraoperative 
anesthetic management, and tacrolimus-based immunosuppression 
were performed using standard protocols, in which tacrolimus-based 
immunosuppression was routinely used (26). 
Postoperative DUS examinations were not routinely done, but 
they were ordered promptly when clinically indicated. If HAT was 
diagnosed by DUS, angiographic confirmation frequently was ob-
tained before UR was performed. During the period covered in this 
article, the technique ofUR became increasingly standardized (Table 
1). After balloon catheter thrombectomy, intraoperative angiography 
was performed to confirm patency of the intrahepatic arterial 
branches. When intrahepatic thrombus could not be cleared, uroki-
nase (50,000-100,000) was administered directly into the donor he-
patic artery (n=7). The hepatic arterial flow was restored with an 
iliac interposition arterial graft, which usually was based on the 
infrarenal aorta (27, 28). 
After UR, all patients were treated with intravenous heparin and 
low molecular weight dextran for 7 days, followed by long-term, 
low-dose aspirin. The heparin dosage was designed to achieve a 
partial thromboplastin time between 1.5 and 2,0 times baseline. In 
selected patients who were at high risk for recurrent HAT, long-term 
anticoagulation with warfarin sodium was used. In these patients, 
the aim was to achieve 1.5-1.8 times prothrombin time prolongation 
by international normalized ratio. 
RESULTS 
During the 2-year period of this study, UR was attempted 
in 17 adult OLT recipients with HAT 3-30 days after OLT 
(median, 7 days; mean, 11 days). The HAT occurred with 12 
primary allografts, 4 second allografts, and 1 third allograft. 
Table 2 shows the type of arterial reconstruction that had 
been used previously. In 14 of the 17 cases, the anastomosis 
TABLE 1. Urgent revascularization after HAT (n=17) 
Technique 
(a) Thrombectomy 
(b) Intraoperative angiography 
(c) Interposition arterial graft (n=10) 
Cd) Residual distal thromboses (n=7) 
Intra-arterial urokinase (50-100,000 U) 
Interposition arterial graft 
(e) Systemic heparin and dextran 40 
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TABLE 2. Urgent revascularization after HAT: arterial anastomo-
________ s:.::i=.s...::a:.::t...::t=he time_o_f_O_L_T _______ _ 
Donor/recipient 
Celiac axis/common hepatic artery 
Celiac axis/iliac arterial graft 
Common hepatic artery/right hepatic artery 
No. of patients (%) 
14 (83) 
2 (11) 
1 (6) 
had been between the donor celiac axis and the recipient 
common hepatic artery. 
Diagnostic Accuracy 
DUS correctly revealed the HAT in all 17 patients. These 
scans almost invariably were obtained to evaluate the cause 
of allograft dysfunction or injury, most often manifested by 
elevations of bilirubin and/or canalicular or hepatocellular 
enzymes. Five patients had unexplained sepsis (Table 3). 
Fourteen of the 17 patients underwent confirmatory angiog-
raphy, but three patients were explored based on the DUS 
findings alone. 
Causes of HAT 
A clear mechanical cause for HAT was identified in five 
patients. In two cases, an intimal dissection was found. A bile 
leak with an associated mycotic aneurysm of the hepatic 
artery and distal thrombosis was found in two other patients, 
both of whom were recipients of second transplants after 
chronic rejection of their primary allografts. The fifth patient 
received a liver from a non-heart-beating donor. Intraopera-
tive angiography performed after thrombectomy revealed dif-
fuse donor arterial spasm. In five additional patients, a pos-
itive cytotoxic antibody cross-match was a nonmechanical 
risk factor for HAT. In the remaining seven patients, no 
specific etiologic factor could be identified. 
Operative Procedures 
UR was accomplished in all 17 patients. In one patient, the 
interposition arterial graft was anastomosed to the recipient 
splenic artery to avoid instrumentation of the atherosclerotic 
aorta. In another patient, the anastomosis to the usual in-
frarenal aortic position used in 15 of the 17 cases was tech-
nically difficult, causing the supraceliac aorta to be used (1, 
29). In seven cases, the arteriogram obtained after thrombec-
tomy showed residual thrombi in the small intrahepatic 
branches. Dissolution of these clots within the allograft was 
accomplished by administering 50,000-100,000 U of uroki-
nase directly into the donor hepatic artery. 
Patient Survival 
None of the patients has had retransplantation. The long-
term patency rate after UR was 88% (15/17). However, six 
patients (35%) died with a patent hepatic artery after a mean 
period of 33 days (range, 6-120 days; median, 17 days). In all 
TABLE 3. Indications for DUS after OLT in 17 patients with HAT 
Indication 
Increased liver function tests and fever 
Increased liver function tests 
Bile leak 
Sepsis 
No. of patients (%) 
4 (24) 
6 (35) 
2 (12) 
5 (29) 
the pa.tients ~Dho died, the patency ofthe hepatic artery was 
establIshed WIth a DUS before the terminal event and/or at 
autopsy (when performed). Eleven patients (65%) are still 
alive, with follow-up of 1-25 months (mean 17 months· me-
dian, 15 months). Table 4 shows the mean ~alues ofthe'liver 
function tests at 3, 6, 9, and 12 months. Two of these 11 
patients had recurrent HAT at 6 and 8 months after UR with 
a single episode of cholangitis at the time of the rec~rrent 
HAT without further symptoms or complications. 
Ostensible candidates for retransplantation. Ten of the 17 
patients were considered to be candidates for retransplanta-
tion at the time of HAT, but did not have the procedure 
because no allografts were immediately available. One of the 
10 "deprived" patients died of Aspergillus pneumonia 5 
months after UR. The other nine patients became long-term 
survivors, and seven still have a patent hepatic artery (Table 
5). 
Noncandidates for retransplantation. Because ofintra-ab-
dominal infections at the time HAT was diagnosed, the other 
seven recipients were not considered candidates for retrans-
plantation. Two (28.5%) ofthe seven patients are still alive, 
while the other five patients continued a complex septic 
course to death (Table 5). 
Morbidity after Revascularization 
All of the patients were anticoagulated with heparin and 
low-molecular-weight dextran. Only one patient (6%) re-
quired reoperation for bleeding after UR. The bleeding site at 
the anastomosis was repaired, and anticoagulation resumed. 
Vascular. Despite anticoagulation, three patients (18%) 
developed occlusion of intrahepatic artery branches. One had 
an asymptomatic thrombosis (diagnosed by DUS) of an 
anomalous right hepatic artery branch. In two other pa-
tients, thrombosis of an anomalous left hepatic arterial 
branch required left lateral segmentectomy for the treatment 
or prevention of septic hepatic gangrene. 
Biliary 
Within 2 weeks after UR, one patient developed a bile leak 
and two other patients had distal common bile duct stric-
tures. Biliary reconstruction was successful in all three 
cases. None of the survivors with patent hepatic artery de-
veloped intrahepatic biliary strictures. 
Other 
Three patients had worsening of hepatic dysfunction, due 
to allograft rejection (n=2) or from a combined hepatitis B 
viruslcytomegalovirus hepatitis (n = 1). 
DISCUSSION 
HAT, or even acute ligation, is usually well tolerated in 
humans because abundant collateral arterial sources protect 
the native liver from ischemia (30). Although the total hep-
atectomy at transplantation disrupts these collaterals, the 
allograft may survive on portal flow only while arterial col-
laterals develop (1). We have estimated that one third of 
arterial thromboses are asymptomatic, one third are not 
immediately life threatening but lead to biliary tract isch-
emia syndromes, and one third cause parenchymal necrosis 
and rapid death if not rectified promptly (3, 7, 13-17). 
Retransplantation has been considered the standard treat-
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Pre-UR 
Total bilirubin 
Median 3.4 
Mean::,:SD 3.4::':1.4 
Aspartate aminotransferase 
Median 401 
Mean::':SD 402.8::':280.9 
Alanine aminotransferase 
Median 
Mean::':SD 
y-Glutamyltranspeptidase 
Median 
Mean::':SD 
464 
413.3::':268.7 
116.5 
121.8::':59.4 
a Two patients with recurrent HAT. 
Post-UR 
1.6 
2.1::-1.2 
282.5 
288.9::':215::':4 
322.5 
346.5::':277.8 
59 
68.8::':35.6 
TABLE 5. Urgent revascularization after HAT 
No. of patients (%) 
Patients surviving (%) 
Hepatic artery patency (%) 
Revascularization 
alternative to re-Tx 
10 (59) 
9 (90) 
8 (80) 
Contraindication 
for re-Tx 
7 (41) 
2 (28.5) 
7 (100) 
ment for HAT. However, our recent experience showed that 
with early diagnosis, DR can eliminate the need for retrans-
plantation in most cases. In the face of the deepening liver 
allograft dysfunctions, failure to attempt DR for early HAT is 
now considered a judgment error in our program. In recipi-
ents who were free from infection when diagnosed with HAT, 
long-term patient and graft survival rates after DR were 
90%, as has been reported by others (24, 31). Although it was 
unusual, long survival was possible for patients who were 
infected and therefore not thought to be candidates for re-
transplantation. Recovery of nearly a third of these septic 
patients after UR may have been more frequent than would 
have been possible with the more radical operation of liver 
replacement. 
The incidence of HAT can be reduced by careful case selec-
tion and attention to surgical technique at both the donor and 
recipient operations. We identified obvious mechanical and 
technical failures in 29% of the cases reported herein. In an 
additional 29%, HAT was associated with a positive cytotoxic 
antibody cross-match. In all cases, early diagnosis of HAT is 
critical if effective reintervention is to be done. We do not 
routinely schedule DUS to follow OL T in adult recipients 
unless there are increased risk factors, such as an older 
recipient or donor, a technically difficult arterial anastomo-
sis, the use of an anomalous hepatic artery for rearterializa-
tion, or a positive cross-match. 
During the 2-year duration of the study, there were no 
false-positive diagnoses of HAT using DUS scans, similar to 
the experience of Kubota et al. (32) in Sweden. Consequently, 
we currently obtain angiographic confirmation of HAT only 
when the DUS diagnosis is equivocal, as has been advocated 
by others (4,24,33,34). Although false-negative DDS scans 
were not recorded during the present study, this can occur, 
particularly in pediatric patients (l0, 11,35). Once the diag-
nosis of HAT is established by either DUS or angiography, 
the symptomatic patient is quickly prepared for reoperation. 
However, if the patient is asymptomatic, the best course may 
3 rno 
-----
1 
1.2::':0.6 
27 
52.5::':66.5 
43 
69.7::':66.2 
62 
82::':53.6 
6rno 
-K-K~--- ~ 
1 
1.l::!:0.6 
31 
44.7::':45.7 
40 
53.5::':37.8 
56.5 
76.5::':55 
9rno 
0.9 
0.9::':0.2 
33 
31::':9.6 
40.5 
40.3::':12.1 
94.5 
129.5::':94.6 
12 rno 
1 
0.9::':0.3 
23.5 
24.5::':12.5 
38 
40::':15.8 
83 
119.2::':99.2 
be careful monitoring rather than operation, because some 
such carefully monitored patients may continue to do well. 
If the decision is made to operate, the standard strategy in 
our center includes thrombectomy and, if necessary, intrahe-
patic arterial thrombolysis with urokinase or other thrombo-
lytic agents. Re-establishment of both the arterial outflow 
and the inflow are critical. We believe that most technical 
errors involve failure to accomplish the latter. With the flex-
ibility allowed by the routine procurement of cadaveric iliac 
arterial grafts (27, 36), there is no excuse for acceptance of a 
weak pulse in the hilum. Autologous saphenous vein grafts 
also have been used (37). 
We do not reuse the recipient celiac axis or hepatic artery 
for UR, or attempt to salvage a hepatic artery segment of the 
first liver graft, because inadequate flow or proximal intimal 
dissections in these vessels often have contributed cryptically 
to the HAT in the first place. Systematic reuse of these 
vessels for DR has been associated with a high failure rate 
(38). Our first choice is to base an interposition graft on the 
recipient aorta, preferably below the renal arteries. 
Postoperative anticoagulation with heparin and dextran is 
of unproved value in adult liver recipients after HAT, but it 
has had a low complication rate (only 6% bleeding). Antico-
agulation has been effective in preventing HAT in high-risk 
pediatric transplant patients (8). 
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